TheJournalofMusculoskeletalMedicine Members: Login | Register
TheJournalofMusculoskeletalMedicine SearchMedica Medline Drugs

Powered by SearchMedica

 
Conferences
News
In the Journals
Gout
Osteoarthritis
Osteoporosis
Rheumatoid Arthritis
Multimedia
Photo Quiz
 


 

Arthritis Supplement Reumofan (or "WOW") Contains Unlisted Medications

February 20, 2013

Here's a notice for your waiting room bulletin board: Manufacturers are recalling Reumofan Plus, an herbal supplement marketed as "100% natural," because it has been found to contain active pharmaceutical ingredients not listed on the packaging: methocarbamol(Drug information on methocarbamol) (a muscle relaxant), dexamethasone(Drug information on dexamethasone) (a corticosteroid), and diclofenac(Drug information on diclofenac) (a non-steiroidal anti-inflammatory drug). The supplement has been used for arthritis, muscle pain, osteoporosis, and other conditions.

Its stated ingredients include curcumin (a component of tumeric), white willow, and shark cartilage.

(MORE: Drug Shortages 2013: What to Know)

The FDA first warned the public about the dangers of Reumofan Plus on in June 2012. Subsequently,it has received reports adverse effects related to the supplement including fatalities, stroke, severe gastrointestinal bleeding, dizziness, insomnia, high blood sugar levels, liver and kidney problems, and corticosteroid withdrawal syndrome.

Two months ago, the FDA warned that Reumofan Plus was being relabeled and sold under the name “WOW.” The FDA has confirmed that “WOW” contains the same unapproved prescription drug ingredients that have been found in Reumofan Plus.

Both of these drugs are manufactured in Mexico by Riger Naturals and sold on various websites, including www.reumoplanusa.com and www.gonepainfree.com. Despite recent warnings, the manufacturer Reumofan USA LLC reportedly has continued online sales of Reumofan Plus. The product has also been sold in the past at retail outlets and on Amazon and eBay.

Healthcare professionals and consumers are encouraged to report problems associated with Reumofan Plus products and “WOW” either online at https://www.accessdata.fda.gov/scripts/medwatch/medwatch-online.htm or by phone at 800-FDA-1088.

 

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

More

Epidural Steroid Meningitis Outbreak: CDC Issues New Physician Guidance

Fungus-Infected Steroid Injections Now Include Joints

Drug Shortages 2013: What to Know

Arthritis Supplement Reumofan (or "WOW") Contains Unlisted Medications






 
TOPIC INDEX

  • Arthritis
  • Fibromyalgia
  • Geriatrics
  • Gout
  • Imaging
  • Juvenile Arthritis
  • Lupus
  • Osteoarthritis
  • Osteoporosis
  • Pain
  • Rheumatoid Arthritis
  • Women


 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent

  • Iontophoretic Administration of Dexamethasone for Musculoskeletal Pain
  • Managing degenerative lumbar spinal stenosis
  • Evaluating edema of the hands
  • Iliopsoas Bursitis
  • Managing Quadriceps Strains for Early Return to Play
  • Doomed Arthritic Knees Rotate More and Never Rest
  • A 45-year-old woman with acute thumb pain
  • Chondroitin Sulfate Use Linked to Reduced Need for Knee Replacement
  • Small Nerve Fibers and Fibromyalgia: Five Signposts to a New Paradigm
  • Brief High-Dose Prednisone Improves Active Ankylosing Spondylitis
  • EULAR/OARSI Consortium Seeks Predictors of OA Injection Success
  • Nine Gaps in Our Understanding of RA: Openings to Yet Better Outcomes
  • New Options for Hepatitis C, Osteoporosis. One Less for Pain
  • Rash Questions for Rheumatologists
  • FDA Approves Golimumab for Ulcerative Colitis
Click here to subscribe to our newsletter





CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy